New England arguably delivers the best ecosystem for launching, growing, and supporting biotech companies in North America. It leads the way in biotech VC funding as well as having a world-renowned academic reputation underpinning private industry's efforts. 

​

With over 430 biotech companies registered in Massachusetts alone, the region is home to not only industry heavyweights and household names, but start-ups at the leading edge of drug discovery and the medical technologies of the future. 

 

COG New England brings together senior decision-makers from across the spectrum of New England, and wider East Coast-based, trial sponsors to hear from thought leaders within the industry, regulators and academia alongside a group of the most trusted and innovative solution providers serving this market for two days of leading multi-stream agenda content and networking engagement at a luxury Boston hotel. 

​

We're delighted to host COG New England as the premier meeting place for the New England clinical trial sector and look forward to welcoming you in Boston in April.